Balyasny Asset Management’s Aveanna Healthcare AVAH Stock Holding History

Balyasny Asset Management’s Portfolio AVAH Stock Details AVAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$476K	Sell	55,561 -11,006	-17%	-$77.6K	﹤0.01%	2534
2026 Q1	$429K	Sell	66,567 -44,150	-40%	-$341K	﹤0.01%	2433
2025 Q4	$905K	Buy	+110,717	New	+$1M	﹤0.01%	2244
2025 Q3	–	Sell	-29,360	Closed	-$154K	–	2901
2025 Q2	$154K	Buy	+29,360	New	+$149K	﹤0.01%	2642
2023 Q1	–	Sell	-49,957	Closed	-$39K	–	2637
2022 Q4	$39K	Buy	49,957 +17,776	+55%	+$18.6K	﹤0.01%	2382
2022 Q3	$48K	Buy	32,181 +18,155	+129%	+$37.3K	﹤0.01%	2483
2022 Q2	$32K	Buy	+14,026	New	+$40.7K	﹤0.01%	2414

Other funds holding AVAH

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

JHWEPV

J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return

NTCM

Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Balyasny Asset Management's AVAH Position: Q2 2026 in Review

Balyasny Asset Management reduced its Aveanna Healthcare (AVAH) stake by 17% in Q2 2026, selling an estimated $77.6K and leaving 55,561 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

Balyasny Asset Management first reported a position in AVAH in Q2 2022 and has held it in 7 quarters since. The position peaked at $905K in Q4 2025. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

Balyasny Asset Management held 55,561 shares of Aveanna Healthcare worth $476K as of Q2 2026.
Balyasny Asset Management sold 11,006 Aveanna Healthcare shares in Q2 2026, an estimated $77.6K.
Aveanna Healthcare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2534 holding.
Balyasny Asset Management first reported a position in Aveanna Healthcare in Q2 2022 and has held it in 7 quarters since.
Balyasny Asset Management's Aveanna Healthcare position peaked at $905K in Q4 2025.
215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.